Denali Therapeutics
Developing drugs for neurodegenerative diseases
- B2B
About Denali Therapeutics
Company dedicated to defeating neurodegenerative diseases through innovative research, brain delivery engineering, biomarkers, and collaborative, impact-focused work environment
Key facts
- Industry
- Biotechnology Research
- Company size
- 251–1,000 employees
- Headquarters
- South San Francisco, California, United States
- Founded
- 2015
- Revenue
- $331MFY2023, publicly reported
- Website
- denalitherapeutics.com
Denali Therapeutics at a glance
Denali Therapeutics is a B2B company in the Biotechnology Research industry, headquartered in South San Francisco, California, United States.
Denali Therapeutics was founded in 2015.
Denali Therapeutics has 251–1,000 employees.
Denali Therapeutics's revenue is $331M (FY2023, publicly reported).
Frequently asked questions about Denali Therapeutics
What is Denali Therapeutics's revenue?
Denali Therapeutics's revenue is $331M (FY2023, publicly reported).
How many employees does Denali Therapeutics have?
Denali Therapeutics has 251–1,000 employees.
Where is Denali Therapeutics headquartered?
Denali Therapeutics is headquartered in South San Francisco, California, United States.
Selling to companies like Denali Therapeutics?
Tamtam finds the companies that match your ideal customer, researches each account and tells you who to contact and when.
Find similar companies